250 related articles for article (PubMed ID: 25301722)
1. The tyrosine phosphatase PTPRO sensitizes colon cancer cells to anti-EGFR therapy through activation of SRC-mediated EGFR signaling.
Asbagh LA; Vazquez I; Vecchione L; Budinska E; De Vriendt V; Baietti MF; Steklov M; Jacobs B; Hoe N; Singh S; Imjeti NS; Zimmermann P; Sablina A; Tejpar S
Oncotarget; 2014 Oct; 5(20):10070-83. PubMed ID: 25301722
[TBL] [Abstract][Full Text] [Related]
2. Novel β-phenylacrylic acid derivatives exert anti-cancer activity by inducing Src-mediated apoptosis in wild-type KRAS colon cancer.
Kim SJ; Noh TH; Son S; Kim DH; Kim W; Lee Y; Choo J; Heo G; Kim MJ; Chung HY; Jung Y; Jung JH; Moon HR; Im E
Cell Death Dis; 2018 Aug; 9(9):877. PubMed ID: 30158525
[TBL] [Abstract][Full Text] [Related]
3. PTPRO plays a dual role in hepatic ischemia reperfusion injury through feedback activation of NF-κB.
Hou J; Xia Y; Jiang R; Chen D; Xu J; Deng L; Huang X; Wang X; Sun B
J Hepatol; 2014 Feb; 60(2):306-12. PubMed ID: 24128416
[TBL] [Abstract][Full Text] [Related]
4. The epidermal growth factor receptor tyrosine kinase inhibitor gefitinib sensitizes colon cancer cells to irinotecan.
Braun AH; Stark K; Dirsch O; Hilger RA; Seeber S; Vanhoefer U
Anticancer Drugs; 2005 Nov; 16(10):1099-108. PubMed ID: 16222152
[TBL] [Abstract][Full Text] [Related]
5. Met and c-Src cooperate to compensate for loss of epidermal growth factor receptor kinase activity in breast cancer cells.
Mueller KL; Hunter LA; Ethier SP; Boerner JL
Cancer Res; 2008 May; 68(9):3314-22. PubMed ID: 18451158
[TBL] [Abstract][Full Text] [Related]
6. CTEN prolongs signaling by EGFR through reducing its ligand-induced degradation.
Hong SY; Shih YP; Li T; Carraway KL; Lo SH
Cancer Res; 2013 Aug; 73(16):5266-76. PubMed ID: 23774213
[TBL] [Abstract][Full Text] [Related]
7. A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.
Yao Z; Darowski K; St-Denis N; Wong V; Offensperger F; Villedieu A; Amin S; Malty R; Aoki H; Guo H; Xu Y; Iorio C; Kotlyar M; Emili A; Jurisica I; Neel BG; Babu M; Gingras AC; Stagljar I
Mol Cell; 2017 Jan; 65(2):347-360. PubMed ID: 28065597
[TBL] [Abstract][Full Text] [Related]
8. Cell surface epidermal growth factor receptors increase Src and c-Cbl activity and receptor ubiquitylation.
Parks EE; Ceresa BP
J Biol Chem; 2014 Sep; 289(37):25537-45. PubMed ID: 25074934
[TBL] [Abstract][Full Text] [Related]
9. Role of protein kinase C and epidermal growth factor receptor signalling in growth stimulation by neurotensin in colon carcinoma cells.
Müller KM; Tveteraas IH; Aasrum M; Ødegård J; Dawood M; Dajani O; Christoffersen T; Sandnes DL
BMC Cancer; 2011 Oct; 11():421. PubMed ID: 21961726
[TBL] [Abstract][Full Text] [Related]
10. Sprouty2 protein enhances the response to gefitinib through epidermal growth factor receptor in colon cancer cells.
Feng YH; Tsao CJ; Wu CL; Chang JG; Lu PJ; Yeh KT; Shieh GS; Shiau AL; Lee JC
Cancer Sci; 2010 Sep; 101(9):2033-8. PubMed ID: 20624167
[TBL] [Abstract][Full Text] [Related]
11. Phosphotyrosine signaling networks in epidermal growth factor receptor overexpressing squamous carcinoma cells.
Thelemann A; Petti F; Griffin G; Iwata K; Hunt T; Settinari T; Fenyo D; Gibson N; Haley JD
Mol Cell Proteomics; 2005 Apr; 4(4):356-76. PubMed ID: 15657067
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells. Modulation of EGF-induced trafficking and signaling.
Huang Y; Kim SO; Jiang J; Frank SJ
J Biol Chem; 2003 May; 278(21):18902-13. PubMed ID: 12642595
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity to gefitinib (Iressa, ZD1839) in non-small cell lung cancer cell lines correlates with dependence on the epidermal growth factor (EGF) receptor/extracellular signal-regulated kinase 1/2 and EGF receptor/Akt pathway for proliferation.
Ono M; Hirata A; Kometani T; Miyagawa M; Ueda S; Kinoshita H; Fujii T; Kuwano M
Mol Cancer Ther; 2004 Apr; 3(4):465-72. PubMed ID: 15078990
[TBL] [Abstract][Full Text] [Related]
14. Cetuximab-induced MET activation acts as a novel resistance mechanism in colon cancer cells.
Song N; Liu S; Zhang J; Liu J; Xu L; Liu Y; Qu X
Int J Mol Sci; 2014 Apr; 15(4):5838-51. PubMed ID: 24714091
[TBL] [Abstract][Full Text] [Related]
15. Src family kinases mediate epidermal growth factor receptor signaling from lipid rafts in breast cancer cells.
Irwin ME; Bohin N; Boerner JL
Cancer Biol Ther; 2011 Oct; 12(8):718-26. PubMed ID: 21775822
[TBL] [Abstract][Full Text] [Related]
16. Related adhesion focal tyrosine kinase and the epidermal growth factor receptor mediate the stimulation of mitogen-activated protein kinase by the G-protein-coupled P2Y2 receptor. Phorbol ester or [Ca2+]i elevation can substitute for receptor activation.
Soltoff SP
J Biol Chem; 1998 Sep; 273(36):23110-7. PubMed ID: 9722539
[TBL] [Abstract][Full Text] [Related]
17. EGFR inhibition evokes innate drug resistance in lung cancer cells by preventing Akt activity and thus inactivating Ets-1 function.
Phuchareon J; McCormick F; Eisele DW; Tetsu O
Proc Natl Acad Sci U S A; 2015 Jul; 112(29):E3855-63. PubMed ID: 26150526
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta1-induced plasminogen activator inhibitor-1 expression in vascular smooth muscle cells requires pp60(c-src)/EGFR(Y845) and Rho/ROCK signaling.
Samarakoon R; Higgins SP; Higgins CE; Higgins PJ
J Mol Cell Cardiol; 2008 Mar; 44(3):527-38. PubMed ID: 18255094
[TBL] [Abstract][Full Text] [Related]
19. Activated Src and Ras induce gefitinib resistance by activation of signaling pathways downstream of epidermal growth factor receptor in human gallbladder adenocarcinoma cells.
Qin B; Ariyama H; Baba E; Tanaka R; Kusaba H; Harada M; Nakano S
Cancer Chemother Pharmacol; 2006 Nov; 58(5):577-84. PubMed ID: 16532343
[TBL] [Abstract][Full Text] [Related]
20. Ultraviolet irradiation can induce evasion of colon cancer cells from stimulation of epidermal growth factor.
Adachi S; Yasuda I; Nakashima M; Yamauchi T; Kawaguchi J; Shimizu M; Itani M; Nakamura M; Nishii Y; Yoshioka T; Hirose Y; Okano Y; Moriwaki H; Kozawa O
J Biol Chem; 2011 Jul; 286(29):26178-87. PubMed ID: 21646361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
